# Top 50 Health Care VC (Venture Capital) Funds in Denmark in June 2026

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 32
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## BioInnovation Institute
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 19
- Stages: Convertible Note, Pre-Seed, Debt Financing
- Focus: Biotechnology, Medical, Health Care

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

## Vaekstfonden
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 18
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

## Export and Investment Fund
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 16
- Stages: Seed, Series A
- Focus: Software, Biotechnology, Health Care

Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.

## PSV
- Type: VC Fund
- Location: Lyngby, Hovedstaden, Denmark
- Relevant deals: 15
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.

## Seed Capital
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 13
- Stages: Seed, Series A
- Focus: Software, Health Care, SaaS

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

## People Ventures
- Type: VC Fund
- Location: Taastrup, Hovedstaden, Denmark
- Relevant deals: 7
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Health Care, Internet of Things

Backing founders with people, money and presence | People Ventures

## Sunstone Life Science Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 7
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

## West Hill Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 6
- Stages: Series A, Seed
- Focus: Software, Health Care, Financial Services

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

## Oskare Capital
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 6
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, Biotechnology, Medical

Oskare Capital is a venture capital firm.

## Gilde Healthcare
- Type: VC Fund
- Location: Utrecht, Utrecht, The Netherlands
- Relevant deals: 5
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Medical

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

## Innovation Fund Denmark
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 4
- Stages: Grant, Pre-Seed, Seed
- Focus: Software, Biotechnology, SaaS

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

## VF Venture
- Type: VC Fund
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, SaaS, Biotechnology

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

## RA Capital Management
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 4
- Stages: Series B, Series C, Post-IPO Equity
- Focus: Biotechnology, Health Care, Therapeutics

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

## Antler
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 4
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Artificial Intelligence, Information Technology

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

## Innovestor
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 4
- Stages: Seed, Pre-Seed
- Focus: Software, Health Care, Information Technology

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

## Delphinus Venture Capital
- Type: VC Fund
- Relevant deals: 4
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Food and Beverage, Hospital

Delphinus Venture Capital is a venture investment management firm.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Crowberry Capital
- Type: VC Fund
- Location: Reykjavík, Gullbringusysla, Iceland
- Relevant deals: 3
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Gaming, Health Care

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

## EIR Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Therapeutics

EIR Ventures is a new Life Science Venture Group in the Nordics.

## Omega Funds
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

## Ugly Duckling Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, Artificial Intelligence

At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale. 

## Ysios Capital
- Type: VC Fund
- Location: San Sebastian, Pais Vasco, Spain
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

## Bioqube Ventures
- Type: VC Fund
- Location: Hasselt, Limburg, Belgium
- Relevant deals: 3
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Therapeutics, Life Science

Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.

## Sagitta Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Health Care, Apps, Mobile

Sagitta Ventures invests in early-stage companies in the Nordics and provides long-term capital backing for well-managed businesses that are seeking minority investors without a defined exit horizon.

## Sweet Capital
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Apps, Software, Mobile

Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).

## DSM Venturing
- Type: VC Fund
- Location: Heerlen, Limburg, The Netherlands
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Manufacturing

Innovators in nutrition, health, and beauty. Together, we bring progress to life by combining the essential, the desirable, and the sustainable. 

## byFounders
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Artificial Intelligence, Health Care

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

## Crista Galli Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Medical, Wellness

Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.

## Forbion Capital Partners
- Type: VC Fund
- Location: Naarden, Noord-Holland, The Netherlands
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Impacting the future of medicine.

## Chr. Augustinus Fabrikker
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Software, Health Care, Medical Device

Chr. Augustinus Fabrikker operates as an investment management firm with a core focus on dedicated ownership of Danish businesses. Founded in 1750, Chr. Augustinus Fabrikker has a capital base of more than 30 billion, a significant player in the Danish business community. It is owned by the Augustinus Foundation, which is one of Denmark'slargest cultural foundations, and also makes significant contributions to research and social initiatives.

## The Footprint Firm
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Renewable Energy, Energy Management

The Footprint Firm is an advisory and investment company with a sole focus on sustainability. 

## Inkef
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Medical

SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!

## Acorn Venture Fund
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed
- Focus: Health Care

Venture Capital

## Novo Ventures
- Type: VC Fund
- Location: Bagsværd, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## Unconventional Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Software, Wellness

Unconventional Ventures invests in startups in the pre-seed and seed stage led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.

## SOSV
- Type: VC Fund
- Location: Princeton, New Jersey, United States
- Relevant deals: 2
- Stages: Seed, Convertible Note, Pre-Seed
- Focus: Biotechnology, Health Care, Software

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

## Industrifonden
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Information Technology

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

## Aescap Venture
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Pharmaceutical, Chemical

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

## VentureFriends
- Type: VC Fund
- Location: Athens, Attiki, Greece
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: FinTech, Software, E-Commerce

VentureFriends is a venture capital fund that invests in tech-enabled companies. VentureFriends (VF) is a venture capital fund specialising in seed stage startups. VF seeks to invest in tech-enabled B2C and B2B startups that can develop a sustainable moat over time and have a sweet spot for PropTech, FinTech, Marketplaces, and SaaS. The fundtypically invests between €0.3M - €2.5M and can follow on up to a total of €5 - 10M. VentureFriends invests predominantly in Europe and is founded by ex-entrepreneurs and angel investors, thus having an entrepreneurial and founder-friendly philosophy.

## Investo Capital
- Type: VC Fund
- Location: Aalborg, Nordjylland, Denmark
- Relevant deals: 2
- Stages: Seed
- Focus: Medical Device, Health Diagnostics, mHealth

Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competentmanagement are essential features. The investment focus is Technology, IT, SAAS- and med-tech.

## SR One
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

## Karolinska
- Type: VC Fund
- Location: Solna, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

## CAPNOVA
- Type: VC Fund
- Location: Aarhus, Midtjylland, Denmark
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, B2B

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

## 14W
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: E-Commerce, Fashion, Health Care

14W is a Venture Capital firm based in New York, focusing on the intersection of technology and consumer behaviour.

## Wellington Partners
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

## Balderton Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Software, Financial Services, Artificial Intelligence

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

## Dawn Biopharma
- Type: VC Fund
- Location: Wilmington, Delaware, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Dawn Biopharma is a global investment firm of KKR.

## CBC Investment Group
- Type: VC Fund
- Location: Gothenburg, Vastra Gotaland, Sweden
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Software, Biotechnology, SaaS

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co